Volume 8, Issue 2
Editorialp. 149
What have the Framingham cohorts taught us about hyperuricemia and gout?
Author(s): V Bhole & E Krishnan
Brief Reportp. 153
Adolescents who are double-jointed at increased risk of joint pain
Author(s): Bulletin Board
Brief Reportp. 154
Fibromyalgia drugs found just as likely to harm as to help
Author(s): Bulletin Board
Brief Reportp. 155
IRHOM2 identified as a new target for rheumatoid arthritis therapy
Author(s): Bulletin Board
Letter to Editorp. 157
Patient-reported impact of rheumatic diseases on work: an update
Author(s): M Munir, K Mankia, D Collins, E Price & L Williamson
Discussion Paperp. 165
Adalimumab: 8 years of experience in rheumatoid arthritis
Author(s): JH Tayar, MA Lopez-Olivo & ME Suarez-Almazor
Case Reportp. 205
Comparison of ultraviolet B-induced cutaneous inflammation and skin pathergy test in Beh�§ets disease
Author(s): M Sayarlioglu, S Kamali, A Cefle, M Inanc, L Ocal, O Aral, M Konice & A Gul
Special Issue Articlep. 213
Understanding why cognitive- behavioral therapy is an effective treatment for adolescents with juvenile fibromyalgia
Author(s): S Sil & S Kashikar- Zuck
Perspective Articlep. 221
Effects of smoking on the clinical phenotype and response to treatment in rheumatoid arthritis
Author(s): V Ruiz- Esquide & R SanmartÃÂÂ
Review Articlep. 233
Recent advances in the management of children with familial Mediterranean fever
Author(s): C Saglam, A Polat, OY Jones & E Demirkaya; FMF Arthritis Vasculitis and Orphan Disease Research in Paediatric Rheumatology (FAVOR)
Review Articlep. 247
Rheumatoid arthritis severity: its underlying prognostic factors and how they can be combined to inform treatment decisions
Author(s): IC Scott, CM Lewis, AP Cope & S Steer
Case Reportp. 159
Survival of an elderly patient with limited cutaneous systemic sclerosis, pretamponade and pulmonary hypertension
Author(s): A Naboush, M Abdallah, D Asti & M Goldstein
